Chimera Bioengineering

📍 South San Francisco, United States🗓 Founded 2015👥 10 employees💰 Last funded Aug 2017
Biotechnology Research🌐 chimera.bio
Website LinkedIn
Chimeras mission is to reprogram life to end cancer, using therapies that restore dignity to patients. We do this with next generation, safer and more potent, CAR T therapeutics.
4
Total investors
4
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2015–2017 · investors recorded per year
201522016120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Chimera Bioengineering?
Chimera Bioengineering has 4 investors on record on gritt.io, including 4 early-stage backers.
When did Chimera Bioengineering last raise funding?
The most recent investment in Chimera Bioengineering recorded on gritt.io was in August 2017.
When was Chimera Bioengineering founded?
Chimera Bioengineering was founded in 2015.
What industry is Chimera Bioengineering in?
Chimera Bioengineering operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Chimera Bioengineering based?
Chimera Bioengineering is headquartered in South San Francisco, United States.